BridgeMD
Selective decontamination of the digestive tract in preventing surgical site infections in elective colorectal surgery: a randomised controlled trial (SELDDEC Trial)
EU CTIS ID: 2025-520725-20-00
What this study is testing
To determine if preoperative oral antibiotics, in the absence of mechanical bowel preparation, reduces the incidence of surgical site infection in elective colorectal surgery
- Therapeutic exploratory (Phase II)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Adult patients (aged ≥ 18 years) scheduled for elective laparoscopic, open and/or robotic assisted colon or rectal surgery for benign or malignant disease
You likely can't join if
- 1) inability to provide informed consent (2) acute surgery for bleeding, perforation or obstruction, (3) uncontrolled diabetes mellitus, (4) preoperative steroid use, (5) antibiotic use within 2 weeks of proposed elective surgery date and (6) previous allergic reaction to the antibiotics utilised in this study. (7) Patients with contraindications to neomycin and erythromycin. (8) Patients with renal and hepatic impairment. (9) Patients who have a positive pregnancy test. (10) Patients requiring more extensive antibiotic prophylaxis.
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.